JPRN-jRCTs021180009招募中2 期
eoadjuvant docetaxel in patients with high-risk prostate cancer - NAC in HRPC
arita Shintaro0 个研究点目标入组 150 人开始时间: 2019年3月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 <= 70age old（—）
- 性别
- Male
入选标准
- •pathologically diagnosed high-risk prostate cancer who have a plan to receive surgical treatment
排除标准
- •.Inappropriate patients for this study judged by the physicians
研究者
相似试验
尚未招募
3 期
Gabapentin for taxane associated acute pain syndrome - randomised, placebo-controlled, crossover trial. The TAPS TrialTaxane associated acute pain syndromeCancer - BreastBreast cancerACTRN12611000666921Sunshine Coast Cancer Centre, Nambour General Hospital126
进行中（未招募）
1 期
eoadjuvant, sequential chemotherapy with docetaxel followed by Fluorouracil, Epirubicin, and Cyclophosphamid every 3 weeks - genome wide expression analysis for identification of a predictive gene signature in patients with primary breast cancer - EXPRESSIOEligible will be only females between 18 - 70 years of age, suffering from histologically confirmed primary breast cancer, nodal status positive or negative, phase cT2, cT3, or cT4 including inflammatory disease. Metastatic disease is excluded. All patients will be treated with 3 cycles Docetaxel and 3 cycles FEC.MedDRA version: 14.1Level: PTClassification code 10006201Term: Breast cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10021974Term: Inflammatory breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006202Term: Breast cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006200Term: Breast cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-006381-29-DEniversitätsmedizin Mainz200
进行中（未招募）
不适用
eoadjuvant chemotherapywith weekly docetaxel followed from concomitant docetaxel-RT in patients with high risk locally advancedprostate cancer - docrtpchigh risk locally advancedprostate cancerMedDRA version: 9.1Level: LLTClassification code 10060862Term: Prostate cancerEUCTR2008-003525-16-ITISTITUTI FISIOTERAPICI OSPITALIERI
进行中（未招募）
不适用
eoadjuvant docetaxel, cisplatin and 5-fluororacil (TPF) followed by radiotherapy plus concomitant chemotherapy or cetuximab versus radiotherapy plus concomitant chemotherapy or cetuximab in patients with locally advanced squamous cell carcinoma of the head and neck. A randomized phase III factorial study - HN07patients with locally advanced squamous cell carcinoma of the head and neckMedDRA version: 9.1Level: LLTClassification code 10060121Term: Squamous cell carcinoma of head and neckEUCTR2007-001938-14-ITAVAPO RICERCHE - VENEZIA
已完成
不适用
eo adjuvant chemotherapy by Docetaxel + S-1 for resentable gasric cabcergastric cancerJPRN-UMIN000015632Department of Frontier Surgery, Graduate school of Medicine, Chiba University20